Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors
- 4 September 2015
- journal article
- review article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 19 (12) , 2273-2282
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- GEP-NETS UPDATE: Interventional radiology: role in the treatment of liver metastases from GEP-NETsEuropean Journal of Endocrinology, 2015
- Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumoursBritish Journal of Surgery, 2013
- Advancements in pancreatic neuroendocrine tumorsExpert Review of Gastroenterology & Hepatology, 2013
- Parenchyma-Sparing Resections for Pancreatic Neuroendocrine TumorsJournal of Gastrointestinal Surgery, 2012
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine TumorsNew England Journal of Medicine, 2011
- Laparoscopic radiofrequency thermal ablation of neuroendocrine hepatic metastases: Long-term follow-upSurgery, 2010
- New drugs in neuroendocrine tumors: rising of new therapeutic philosophies?Current Opinion in Oncology, 2010
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II StudyJournal of Clinical Oncology, 2008
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation?Journal of Hepatology, 2007